Billy W. Loo, Jr., MD, PhD, DABR
Publication Details
-
Metabolic tumor burden predicts for disease progression and death in lung cancer.
Int J Radiat Oncol Biol Phys. 2007; (2): 328-33
In lung cancer, stage is an important prognostic factor for disease progression and survival. However, stage may be simply a surrogate for underlying tumor burden. Our purpose was to assess the prognostic value of tumor burden measured by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging.
Help
Trial Administration